Placental Maternal Vascular Malperfusion is Associated with Prepregnancy and Early Pregnancy Maternal Cardiovascular and Thrombotic Profiles. 2022

Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
Department of Obstetrics, Gynecology & Reproductive Sciences, University of Vermont Larner College of Medicine, Burlington, VT, United States.

Characteristics of maternal vascular malperfusion (MVM) are frequently observed in placentas from pregnancies impacted by preeclampsia, intrauterine growth restriction, preterm labor, and intrauterine fetal demise. We sought to evaluate the associations of features of MVM with subclinical measures of cardiovascular health and coagulation potential in healthy young women. Sixty-three healthy young women were recruited and assessed prior to pregnancy on cycle day 9 ± 4, at gestational age 90 ± 6 of early pregnancy, and gestational age 216 ± 5 of late pregnancy. Women were assessed for plasma volume, blood pressure, response to volume loading, cardiac output, and uterine hemodynamics. Platelet-poor plasma was collected to assess thrombin generation on a subset of 33 women at all time points. Following delivery, placentas were collected and analyzed for evidence of MVM. Thrombin generation (TG) was evaluated in the presence of tissue factor (TF) with and without recombinant soluble thrombomodulin (TM). For each, we compared TG lagtime, peak level, and endogenous thrombin potential (ETP). Comparisons were made between dichotomized presence and absence of each individual feature of MVM and cardiovascular and coagulation features. Mean ± standard deviation are presented. Women were 31 ± 4 years of age, body mass index of 24 ± 5 kg/m2, 86% white race, and 80% nulliparous. MVM occurred in 70% of placentas, with infarcts and agglutination (44%), decidual arteriopathy (40%), accelerated villous maturation (32%), placental hypoplasia (29%), and distal villous hypoplasia (17%) documented. Decidual arteriopathy and distal villous hypoplasia were associated with prepregnancy maternal physiology, including decreased plasma volume and subclinical cardiovascular variations. All assessed MVM characteristics had identifiable early pregnancy physiologic characteristics consistent with altered cardiovascular function and decreased uterine response to pregnancy when compared with women who did and did not develop MVM. Accelerated villous maturation was the only MVM feature to differ by thrombin generation parameters in early pregnancy. Thrombin generation potential and blood pressure were elevated in late pregnancy in women who developed decidual arteriopathy. Prepregnancy health status and adaptation to pregnancy play important roles in pregnancy outcomes. Both cardiovascular health and thrombin generation potential may influence early placentation. Longitudinal assessment of subclinical maternal factors may allow for better understanding of the etiologies of MVM lesions, as well as allow for identification of a timeline of the origins of placental pathologies.

UI MeSH Term Description Entries

Related Publications

Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
August 2023, Journal of reproductive immunology,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
January 2017, Placenta,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
July 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
November 2021, Journal of gynecology obstetrics and human reproduction,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
June 2020, Archives of gynecology and obstetrics,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
August 2014, Placenta,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
June 2017, TH open : companion journal to thrombosis and haemostasis,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
May 2024, BJOG : an international journal of obstetrics and gynaecology,
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
March 2021, Rheumatology (Oxford, England),
Carole A McBride, and Ira M Bernstein, and Amelia B Sybenga, and Kelley C McLean, and Thomas Orfeo, and Maria Cristina Bravo
July 2018, BJOG : an international journal of obstetrics and gynaecology,
Copied contents to your clipboard!